Clinical Trial Update: PREVENT: Promus BTK [Phase 2]

View source ↗

Summary

This update indicates that the Phase 2 PREVENT trial evaluating Promus BTK for peripheral arterial disease has completed. The snippet does not include trial res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Promus BTK

Snippet

Sponsor: Flanders Medical Research Program | Conditions: Peripheral Arterial Disease | Phase 2 | Status: COMPLETED